Menarini Silicon Biosystems, S.p.A., headquartered in Italy, is a pioneering company in the biotechnology sector, specialising in liquid biopsy and single-cell analysis. Founded in 2007, the company has established itself as a leader in the development of innovative technologies that enhance cancer diagnostics and research. With a strong presence in Europe and North America, Menarini Silicon Biosystems offers unique products such as the DEPArray™ system, which enables the isolation and characterisation of rare cells from complex samples. This cutting-edge technology sets the company apart in the competitive landscape of molecular diagnostics. Recognised for its contributions to personalised medicine, Menarini Silicon Biosystems continues to advance the field with a commitment to improving patient outcomes through precise and efficient diagnostic solutions.
How does Menarini Silicon Biosystems, S.p.A.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Menarini Silicon Biosystems, S.p.A.'s score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Menarini Silicon Biosystems, S.p.A., headquartered in Italy, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is identified as a current subsidiary and inherits its climate commitments and data from its parent organisation, Menarini Group. Despite the lack of specific emissions data, Menarini Silicon Biosystems is part of a corporate family that may have overarching climate initiatives. However, no specific reduction targets or climate pledges have been documented for this subsidiary. As a current subsidiary, Menarini Silicon Biosystems may align with broader sustainability goals set by its parent company, but details on these initiatives are not explicitly provided. The absence of reported emissions and reduction targets suggests that the company may still be in the process of establishing its climate strategy or reporting framework. In summary, while Menarini Silicon Biosystems, S.p.A. does not currently disclose specific emissions data or reduction commitments, it is positioned within a corporate structure that may influence its future climate actions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Menarini Silicon Biosystems, S.p.A. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
